| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/2005 | EP1499621A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
| 01/26/2005 | EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections |
| 01/26/2005 | EP1499608A1 Substituted imidazole derivatives: gaba a receptor ligands |
| 01/26/2005 | EP1499606A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499603A1 Antiviral lactone-ureas |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499593A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/26/2005 | EP1499391A2 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499356A1 Methods of treatment and diagnosis of patients with hepatitis c infection |
| 01/26/2005 | EP1499354A2 Methods of using cytokine antagonists to treat hiv infection and aids |
| 01/26/2005 | EP1499348A2 Multi plasmid system for the production of influenza virus |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499328A1 Methods of treating necrotizing enterocolitis |
| 01/26/2005 | EP1499326A1 Oxolide antibacterials |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1499315A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499290A1 Warming and nonirritating lubricant compositions |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1441704B1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1406610B1 Use of substituted gamma-lactone compounds as medicaments |
| 01/26/2005 | EP1399164B1 Metal salts as antimycotic agents |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1233748B1 Retinaldehyde combination with antifungal activity |
| 01/26/2005 | EP1165091B1 Pharmaceutical emulsions for retroviral protease inhibitors |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP1129723B1 Combined vaccine against both hav and measle virus and method of producing it |
| 01/26/2005 | EP1107981B1 Synthesis of ring-modified cyclic peptide analogs |
| 01/26/2005 | EP1061950B1 Live vaccine for human immunodeficiency virus |
| 01/26/2005 | EP1058558B1 Adjuvated, live recombinant vaccines against influenza- and herpesviruse |
| 01/26/2005 | EP1015595B1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0854702B1 Antimicrobial compositions containing a c 3-c 6 alcohol |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571663A Dosage forms, devices and methods of treatment |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571637A Use of cystathionine |
| 01/26/2005 | CN1570101A Optimized SARS coronary virus N protein gene |
| 01/26/2005 | CN1569904A Anti AIDS activity compound and its preparation method |
| 01/26/2005 | CN1569902A Active oligose derivative and its preparation method |
| 01/26/2005 | CN1569895A Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 01/26/2005 | CN1569893A Antigen epitope of gold staphylococcus virulence factor regulatory protein and its mimic epitope and use thereof |
| 01/26/2005 | CN1569891A Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use |
| 01/26/2005 | CN1569889A Cyclo-polypeptides capable of combining with autocrine RNAIII activator protein of gold staphylococcus and its pharmaceutical use |
| 01/26/2005 | CN1569881A CpG-containing single chain deoxy-oligonucleotide having anti-influenza virus |
| 01/26/2005 | CN1569878A siRNA nucleic acid sequence for SARS coronavirus causing gene and its pharmaceutical use |
| 01/26/2005 | CN1569873A Antisense nucleic acid sequence for SARS coronavirus gene and its pharmaceutical use |
| 01/26/2005 | CN1569872A Antisense nucleic acid for inhibiting SARS virus gene expression and its use |
| 01/26/2005 | CN1569861A Pharmaceutical acid addition salt of adefovir dipivoxil and its pharmaceutical use |
| 01/26/2005 | CN1569843A Preparation method for sulfadoxine |
| 01/26/2005 | CN1569841A SARS coronavirus 3CL protease inhibitor and its use |
| 01/26/2005 | CN1569777A Chiral source and pharmaceutical salt or complex of organic alkali drug |
| 01/26/2005 | CN1569233A Method for manufacturing gene medicine for preventing and treating SARS and its medicinal prescription |
| 01/26/2005 | CN1569231A Specific antibody IgY immune preparation and its application in the prevention and treatment of mycobacterium tuberculosis infection |
| 01/26/2005 | CN1569229A IgY product for resisting mouth and upper respiratory tract infection and its application |
| 01/26/2005 | CN1569228A SARS vaccine and its preparation method and application |
| 01/26/2005 | CN1569225A Recombinant human interferon alpha nebula |
| 01/26/2005 | CN1569223A Freeze-dried interferon spray and its preparation method |
| 01/26/2005 | CN1569220A Application of gene recombined anti fungus peptide in the treatment of eumycetes infection |
| 01/26/2005 | CN1569208A Antibiotic and antiinflammation traditional medicine composition capable of antibiotic |
| 01/26/2005 | CN1569204A Croton contained medicinal composition for treating tuberculosis and its preparing process |
| 01/26/2005 | CN1569189A Medicine for treating hepatitis A and B |
| 01/26/2005 | CN1569177A Compound hawthorn fruit oral liquid |
| 01/26/2005 | CN1569176A Pure natural compound oral liquid of hawthorn fruit for fowl and livestock and its processing method |
| 01/26/2005 | CN1569171A Health food for preventing and treating influenza |
| 01/26/2005 | CN1569170A Hog cholera treating medicine |
| 01/26/2005 | CN1569169A 'Shuanghuanglian' effervescence tablet and its preparation |
| 01/26/2005 | CN1569168A Chinese medicinal composition for treating typhoid |
| 01/26/2005 | CN1569133A 'Shuanghuanglian' effervescence tablet and its preparation |
| 01/26/2005 | CN1569128A Livestock feedstuff addictive with Chinese medicine for preventing and treating aftosa and its preparation |
| 01/26/2005 | CN1569126A Medicine for treating tuberculosis and preparing method |
| 01/26/2005 | CN1569122A Medicinal composition for treating high fever due to virus infection and its preparation method |
| 01/26/2005 | CN1569090A Pharmaceutical composition for treating AlDS |
| 01/26/2005 | CN1569089A Medicine for treating AIDS |
| 01/26/2005 | CN1569086A Medicine for treating tuberculosis and method for preparing the same |
| 01/26/2005 | CN1569084A Disturbing oil for preventing and treating SARS |
| 01/26/2005 | CN1569081A Antivirus Chinese traditional medicine and its preparation method |
| 01/26/2005 | CN1569073A Liver disease treating medicine |
| 01/26/2005 | CN1569058A Innovative technique for processing aloe raw material with high stability |
| 01/26/2005 | CN1569052A Medicine for killing SARS virus |
| 01/26/2005 | CN1569047A Novel method for preparing a liver benefiting medicine and its preparation |
| 01/26/2005 | CN1569046A Novel method for preparing a liver benefiting medicine and its preparation |
| 01/26/2005 | CN1569043A Coated micro capsule of lactic acid bacteria and its preparation |